The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) on December 16 announced that the U.S. Food and Drug Administration (FDA) granted approval for Basaglar ...
By Shreoshree Chakrabarty: For individuals managing diabetes, insulin must be administered into the subcutaneous tissue—the layer of fat located between the skin and muscle. This tissue, also called ...
People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...
Medicare Part D may cover Basaglar, a long-acting insulin, and under the Inflation Reduction Act, the cost should not exceed $35 per month. The availability of Basaglar under Medicare Part D depends ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results